PER2CD4+TIFN-γ

Yulan Ye1, Changqin Liu2, Ruijin Wu2

  • 1Center for IBD Research and Department of Gastroenterology, The Shanghai Tenth People's Hospital of Tongji University, Shanghai 200072, China; Department of Gastroenterology, Suzhou Municipal Hospital Affiliated to Nanjing Medical University, Suzhou 215008, China.

Mucosal immunology
|August 3, 2024
PubMed
概括

昼夜钟蛋白PER2在性结肠炎 (UC) CD4+ T细胞中降低,影响疾病的严重程度. 恢复PER2通过降低ADAM12的调节来抑制炎症,这表明PER2是UC的治疗点.